Skip to content

Clinical trials

Phase 1/2 Sarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1/2 Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20016
20022
20031
20063
20075
20083
20095
20105
20114
20123
20136
20146
20155
20169
201712
201811
20198
202015
202111
20229
20238
20243
20258
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Recruiting34
Terminated22
Unknown status14
Active, not recruiting13
Not yet recruiting5
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)11
Eli Lilly and Company5
Grupo Espanol de Investigacion en Sarcomas5
Fred Hutchinson Cancer Center4
Hutchmed3
Institut Bergonié3
M.D. Anderson Cancer Center3
Memorial Sloan Kettering Cancer Center3
Royal Marsden NHS Foundation Trust3
Sarcoma Oncology Research Center, LLC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma167
Ovarian Neoplasms28
Neoplasm Metastasis26
Breast Neoplasms25
Melanoma25
Neoplasms22
Carcinoma, Non-Small-Cell Lung21
Colorectal Neoplasms21
Sarcoma, Ewing20
Stomach Neoplasms18

Trials

Showing 26 to 50 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.